 Home > Medical News > Latest Medical News > Henlius PD-1 Monoclonal Antibody Slulimumab Injection Approved for Marketing

Henlius PD-1 Monoclonal Antibody Slulimumab Injection Approved for Marketing

 Last Update: 2022-04-22
 Source: Internet
 Author: User

Tags

high ferritin symptoms

high oleic soybean

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On March 24, the latest approval document issued by the State Food and Drug Administration showed that Fuhong Henlius PD-1 monoclonal antibody slulimumab injection was approved for marketing, for patients with unresectable or metastatic high-grade microscopic disease that have failed standard treatment.

In April 2021, slulimumab submitted its first indication marketing application in China, targeting unresectable or metastatic highly microsatellite unstable solid tumors that have failed standard therapy

On December 7, 2021, Henlius announced a randomized, double-blind, double-blind, randomized clinical trial of the PD-1 inhibitor slulimumab combined with chemotherapy in previously untreated extensive-stage small cell lung cancer (ES-SCLC).

Henlius is also developing innovative drugs simultaneously, and a number of innovative drugs have entered the clinic, including: anti-EGFR monoclonal antibody, anti-VEGFR monoclonal antibody, anti-PD-L1 monoclonal antibody, anti-LAG-3 monoclonal antibody, anti-CD73 monoclonal antibody, 4-1BB/EGFR double antibody,

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.